Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer

The Lancet Diabetes and Endocrinology

Volumn 3, Issue 7, 2015, Pages 545-555

  Tonorezos, Emily S ^a   Hudson, Melissa M ^b   Edgar, Angela B ^c   Kremer, Leontien C ^d   Sklar, Charles A ^a   Wallace, W Hamish B ^c   Oeffinger, Kevin C ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^d EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; ALKYLATING AGENT; CORTICOSTEROID; DEXAMETHASONE; GLUCOSE; HEMOGLOBIN A1C; LUTEINIZING HORMONE; METHOTREXATE; TESTOSTERONE; THYROTROPIN; ANTINEOPLASTIC AGENT;

ABDOMINAL RADIOTHERAPY; ACP1 GENE; ACUTE LYMPHOBLASTIC LEUKEMIA; ADVERSE OUTCOME; ARTHRALGIA; ASTROCYTOMA; BONE DENSITY; BONE NECROSIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CANCER SURVIVOR; CARDIOMYOPATHY; CERVICAL SPINE RADIOGRAPHY; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; COHORT ANALYSIS; CRANIOPHARYNGIOMA; DIABETES MELLITUS; DNA POLYMORPHISM; DOSAGE SCHEDULE COMPARISON; DRUG MEGADOSE; DYSLIPIDEMIA; EWING SARCOMA; GENE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROIDISM; HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHYROIDISM; INFERTILITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; JOINT SWELLING; LONG TERM CARE; MEDULLOBLASTOMA; NASOPHARYNX TUMOR; NEPHROBLASTOMA; NEUROBLASTOMA; NEUROECTODERM TUMOR; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHODGKIN LYMPHOMA; OBESITY; ORBIT TUMOR; OSTEOBLAST; PAPILLARY CARCINOMA; PATIENT SATISFACTION; PELVIC IRRADIATION; PELVIS CANCER; PRACTICE GUIDELINE; PREMATURE OVARIAN FAILURE; PREVALENCE; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; SKULL BASE TUMOR; SKULL IRRADIATION; SOFT TISSUE CANCER; SOFT TISSUE SARCOMA; THYROID DISEASE; THYROID TUMOR; TREATMENT DURATION; VITAMIN D DEFICIENCY; WHOLE BODY RADIATION; ADOLESCENT; ADULT; ADVERSE EFFECTS; DISEASE MANAGEMENT; ENDOCRINE SYSTEM DISEASES; NEOPLASMS; RADIOTHERAPY; RISK FACTOR; SURVIVOR; YOUNG ADULT;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; DISEASE MANAGEMENT; ENDOCRINE SYSTEM DISEASES; HUMANS; NEOPLASMS; RADIOTHERAPY; RISK FACTORS; SURVIVORS; YOUNG ADULT;

EID: 84934438306     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(15)00038-8     Document Type: Review

References (125)

1. Howlader N, Noone A, Krapcho M, et al. SEER cancer statistics review, 1975-2011 (accessed April 1, 2014). http://seer.cancer.gov/csr/1975_2011.
2. Cancer statistics Cancer Research UK, (accessed Nov 21, 2014). http://www.cancerresearchuk.org/cancer-info/cancerstats/childhoodcancer.
3. Birch JM, Pang D, Alston RD, et al. Survival from cancer in teenagers and young adults in England, 1979-2003. Br J Cancer 2008, 99:830-835.
4. Robison LL, Hudson MM Survivors of childhood and adolescent cancer: life-long risks and responsibilities. Nat Rev Cancer 2014, 14:61-70.
5. Haupt R, Spinetta JJ, Ban I, et al. Long term survivors of childhood cancer: cure and care. The Erice statement. Eur J Cancer 2007, 43:1778-1780.
6. Hudson MM, Ness KK, Gurney JG, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 2013, 309:2371-2381.
7. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006, 355:1572-1582.
8. Reulen RC, Frobisher C, Winter DL, et al. Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA 2011, 305:2311-2319.
9. Armstrong GT, Kawashima T, Leisenring W, et al. Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study. J Clin Oncol 2014, 32:1218-1227.
10. De Fine Licht S, Winther JF, Gudmundsdottir T, et al. Hospital contacts for endocrine disorders in Adult Life after Childhood Cancer in Scandinavia (ALiCCS): a population-based cohort study. Lancet 2014, 383:1981-1989.
11. Ford JS, Kawashima T, Whitton J, et al. Psychosexual functioning among adult female survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol 2014, 32:3126-3136.
12. Oeffinger KC, Hudson MM Long-term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivors. CA Cancer J Clin 2004, 54:208-236.
13. Skinner R, Oeffinger KC Developing international consensus for late effects screening and guidance. Curr Opin Support Palliat Care 2013, 7:303-308.
14. Sieswerda E, Postma A, van Dalen EC, et al. The Dutch Childhood Oncology Group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivors. Ann Oncol 2012, 23:2191-2198.
15. Long-term follow-up guidelines for survivors of childhood, adolescent and young adult cancers, version 4.0 Children's Oncology Group, (accessed Feb 23, 2015). http://www.survivorshipguidelines.org.
16. Long term follow up of survivors of childhood cancer (SIGN publication no. 132) March 2013, Scottish Intercollegiate Guidelines Network, SIGN, Edinburgh, (accessed Feb 23, 2015). http://www.sign.ac.uk/pdf/sign132.pdf.
17. Skinner R, Wallace WHB, Levitt GA Long term follow up therapy based guidelines 2005, The United Kingdom Children's Cancer Study Group. 2nd edn.
18. Kremer LC, Mulder RL, Oeffinger KC, et al. A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer 2013, 60:543-549.
19. Anderson RA, Mitchell RT, Kelsey TW, Spears N, Telfer EE, Wallace WHB. Cancer treatment and fertility: strategies for fertility preservation in children and young adults. Lancet Diabetes Endocrinol (in press).
20. Toogood A, Crowne E, Gleeson H, Benghiat H, Sanghera P. Effect of cancer treatment on hypothalamic-pituitary function. Lancet Diabetes Endocrinol (in press).
21. Hudson MM, Neglia JP, Woods WG, et al. Lessons from the past: opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies. Pediatr Blood Cancer 2012, 58:334-343.
22. Darzy KH, Shalet SM Hypopituitarism as a consequence of brain tumours and radiotherapy. Pituitary 2005, 8:203-211.
23. Sklar C, Wolden S Therapy for pediatric brain tumors and the risk of growth hormone deficiency. J Clin Oncol 2011, 29:4743-4744.
24. Mulder RL, Kremer LC, van Santen HM, et al. Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: a systematic review. Cancer Treat Rev 2009, 35:616-632.
25. Follin C, Thilén U, Osterberg K, Björk J, Erfurth EM Cardiovascular risk, cardiac function, physical activity, and quality of life with and without long-term growth hormone therapy in adult survivors of childhood acute lymphoblastic leukemia. J Clin Endocrinol Metab 2010, 95:3726-3735.
26. Sklar C Maintenance of ovarian function and risk of premature menopause related to cancer treatment. J Natl Cancer Inst Monogr 2005, 2005:25-27.
27. Chemaitilly W, Sklar CA Endocrine complications in long-term survivors of childhood cancers. Endocr Relat Cancer 2010, 17:R141-R159.
28. Meacham LR, Sklar CA, Li S, et al. Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study. Arch Intern Med 2009, 169:1381-1388.
29. Gurney JG, Ness KK, Sibley SD, et al. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer 2006, 107:1303-1312.
30. Oeffinger KC, Mertens AC, Sklar CA, et al. Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2003, 21:1359-1365.
31. Garmey EG, Liu Q, Sklar CA, et al. Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2008, 26:4639-4645.
32. Meacham LR, Chow EJ, Ness KK, et al. Cardiovascular risk factors in adult survivors of pediatric cancer-a report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev 2010, 19:170-181.
33. Nottage KA, Ness KK, Li C, Srivastava D, Robison LL, Hudson MM Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia-from the St. Jude Lifetime Cohort. Br J Haematol 2014, 165:364-374.
34. Didi M, Didcock E, Davies HA, Ogilvy-Stuart AL, Wales JK, Shalet SM High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood. J Pediatr 1995, 127:63-67.
35. Van Dongen-Melman JE, Hokken-Koelega AC, Hählen K, De Groot A, Tromp CG, Egeler RM Obesity after successful treatment of acute lymphoblastic leukemia in childhood. Pediatr Res 1995, 38:86-90.
36. Zee P, Chen CH Prevalence of obesity in children after therapy for acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol 1986, 8:294-299.
37. Reilly JJ, Brougham M, Montgomery C, Richardson F, Kelly A, Gibson BE Effect of glucocorticoid therapy on energy intake in children treated for acute lymphoblastic leukemia. J Clin Endocrinol Metab 2001, 86:3742-3745.
38. Reilly J, Ventham J, Newell J, Aitchison T, Wallace W, Gibson B Risk factors for excess weight gain in children treated for acute lymphoblastic leukaemia. Int J Obes Relat Metab Disord 2000, 24:1537-1541.
39. Oeffinger KC, Adams-Huet B, Victor RG, et al. Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 2009, 27:3698-3704.
40. Tonorezos ES, Vega GL, Sklar CA, et al. Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia. Pediatr Blood Cancer 2012, 58:31-36.
41. Ness KK, Kaste SC, Zhu L, et al. Skeletal, neuromuscular and fitness impairments among children with newly diagnosed acute lymphoblastic leukemia. Leuk Lymphoma 2014, 20:1-8.
42. Tonorezos ES, Snell PG, Moskowitz CS, et al. Reduced cardiorespiratory fitness in adult survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2013, 60:1358-1364.
43. Inge TH, Pfluger P, Zeller M, et al. Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy. Nat Clin Pract Endocrinol Metab 2007, 3:606-609.
44. Tonorezos ES, Robien K, Eshelman-Kent D, et al. Contribution of diet and physical activity to metabolic parameters among survivors of childhood leukemia. Cancer Causes Control 2013, 24:313-321.
45. Smith WA, Li C, Nottage KA, et al. Lifestyle and metabolic syndrome in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort Study. Cancer 2014, 120:2742-2750.
46. Jones LW, Liu Q, Armstrong GT, et al. Exercise and risk of major cardiovascular events in adult survivors of childhood Hodgkin lymphoma: a report from the childhood cancer survivor study. J Clin Oncol 2014, 32:3643-3650.
47. Slater ME, Ross JA, Kelly AS, et al. Physical activity and cardiovascular risk factors in childhood cancer survivors. Pediatr Blood Cancer 2014, 62:305-310.
48. Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013, 368:1279-1290.
49. Bölling T, Geisenheiser A, Pape H, et al. Hypothyroidism after head-and-neck radiotherapy in children and adolescents: preliminary results of the "Registry for the Evaluation of Side Effects After Radiotherapy in Childhood and Adolescence" (RiSK). Int J Radiat Oncol Biol Phys 2011, 81:e787-e791.
50. Chow EJ, Friedman DL, Stovall M, et al. Risk of thyroid dysfunction and subsequent thyroid cancer among survivors of acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 2009, 53:432-437.
51. Hancock SL, Cox RS, McDougall IR Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991, 325:599-605.
52. Sklar C, Whitton J, Mertens A, et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2000, 85:3227-3232.
53. Vogelius IR, Bentzen SM, Maraldo MV, Petersen PM, Specht L Risk factors for radiation-induced hypothyroidism: a literature-based meta-analysis. Cancer 2011, 117:5250-5260.
54. Metzger ML, Hudson MM, Somes GW, et al. White race as a risk factor for hypothyroidism after treatment for pediatric Hodgkin's lymphoma. J Clin Oncol 2006, 24:1516-1521.
55. Bhatti P, Veiga LH, Ronckers CM, et al. Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res 2010, 174:741-752.
56. Haddy N, El-Fayech C, Guibout C, et al. Thyroid adenomas after solid cancer in childhood. Int J Radiat Oncol Biol Phys 2012, 84:e209-e215.
57. Metzger ML, Howard SC, Hudson MM, et al. Natural history of thyroid nodules in survivors of pediatric Hodgkin lymphoma. Pediatr Blood Cancer 2006, 46:314-319.
58. Sigurdson AJ, Ronckers CM, Mertens AC, et al. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study. Lancet 2005, 365:2014-2023.
59. Veiga LH, Lubin JH, Anderson H, et al. A pooled analysis of thyroid cancer incidence following radiotherapy for childhood cancer. Radiat Res 2012, 178:365-376.
60. Van Santen HM, Tytgat GA, Van de Wetering MD, et al. Differentiated thyroid carcinoma after 131I-MIBG treatment for neuroblastoma during childhood: description of the first two cases. Thyroid 2012, 22:643-646.
61. Holmqvist AS, Olsen JH, Andersen KK, et al. Adult life after childhood cancer in Scandinavia: diabetes mellitus following treatment for cancer in childhood. Eur J Cancer 2014, 50:1169-1175.
62. De Vathaire F, El-Fayech C, Ben Ayed FF, et al. Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort study. Lancet Oncol 2012, 13:1002-1010.
63. Van Nimwegen FA, Schaapveld M, Janus CP, et al. Risk of diabetes mellitus in long-term survivors of Hodgkin lymphoma. J Clin Oncol 2014, 32:3257-3263.
64. Sarri Y, Conill C, Verger E, Tomas C, Gomis R Effects of single dose irradiation on pancreatic beta-cell function. Radiother Oncol 1991, 22:143-144.
65. Cicognani A, Cacciari E, Mancini AF, et al. Abnormal insulin response to glucose following treatment for Wilms' tumor in childhood. Eur J Pediatr 1997, 156:371-375.
66. Letourneau JM, Ebbel EE, Katz PP, et al. Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer. Cancer 2012, 118:1933-1939.
67. Green DM, Sklar CA, Boice JD, et al. Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study. J Clin Oncol 2009, 27:2374-2381.
68. Morgan S, Anderson RA, Gourley C, Wallace WH, Spears N How do chemotherapeutic agents damage the ovary?. Hum Reprod Update 2012, 18:525-535.
69. Lopes F, Smith R, Anderson RA, Spears N Docetaxel induces moderate ovarian toxicity in mice, primarily affecting granulosa cells of early growing follicles. Mol Hum Reprod 2014, 20:948-959.
70. Anderson RA, Wallace WH Antimüllerian hormone, the assessment of the ovarian reserve, and the reproductive outcome of the young patient with cancer. Fertil Steril 2013, 99:1469-1475.
71. Kenney LB, Laufer MR, Grant FD, Grier H, Diller L High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer 2001, 91:613-621.
72. Sklar C Reproductive physiology and treatment-related loss of sex hormone production. Med Pediatr Oncol 1999, 33:2-8.
73. Papadakis V, Vlachopapadopoulou E, Van Syckle K, et al. Gonadal function in young patients successfully treated for Hodgkin disease. Med Pediatr Oncol 1999, 32:366-372.
74. Romerius P, Ståhl O, Moëll C, et al. Hypogonadism risk in men treated for childhood cancer. J Clin Endocrinol Metab 2009, 94:4180-4186.
75. Bakker B, Oostdijk W, Bresters D, Walenkamp MJ, Vossen JM, Wit JM Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood. Bone Marrow Transplant 2004, 33:1049-1056.
76. Sanders JE Endocrine complications of high-dose therapy with stem cell transplantation. Pediatr Transplant 2004, 8(suppl 5):39-50.
77. Armenian SH, Sun CL, Vase T, et al. Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease. Blood 2012, 120:4505-4512.
78. Baker KS, Ness KK, Weisdorf D, et al. Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Leukemia 2010, 24:2039-2047.
79. Chemaitilly W, Boulad F, Oeffinger KC, Sklar CA Disorders of glucose homeostasis in young adults treated with total body irradiation during childhood: a pilot study. Bone Marrow Transplant 2009, 44:339-343.
80. Chow EJ, Simmons JH, Roth CL, et al. Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation. Biol Blood and Marrow Transplant 2010, 16:1674-1681.
81. Oudin C, Simeoni M-C, Sirvent N, et al. Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia. Blood 2011, 117:4442-4448.
82. Majhail NS, Challa TR, Mulrooney DA, Baker KS, Burns LJ Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2009, 15:1100-1107.
83. Sanders JE, Hoffmeister PA, Woolfrey AE, et al. Thyroid function following hematopoietic cell transplantation in children: 30 years' experience. Blood 2009, 113:306-308.
84. Wallace WH, Thomson AB, Saran F, Kelsey TW Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys 2005, 62:738-744.
85. Meirow D, Biederman H, Anderson RA, Wallace WH Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol 2010, 53:727-739.
86. Girard P, Auquier P, Barlogis V, et al. Symptomatic osteonecrosis in childhood leukemia survivors: prevalence, risk factors and impact on quality of life in adulthood. Haematologica 2013, 98:1089-1097.
87. Kaste SC, Ahn H, Liu T, et al. Bone mineral density deficits in pediatric patients treated for sarcoma. Pediatr Blood Cancer 2008, 50:1032-1038.
88. Davies JH, Evans BA, Jenney ME, Gregory JW Skeletal morbidity in childhood acute lymphoblastic leukaemia. Clin Endocrinol (Oxf) 2005, 63:1-9.
89. Elmantaser M, Stewart G, Young D, Duncan R, Gibson B, Ahmed SF Skeletal morbidity in children receiving chemotherapy for acute lymphoblastic leukaemia. Arch Dis Child 2010, 95:805-809.
90. Mandel K, Atkinson S, Barr RD, Pencharz P Skeletal morbidity in childhood acute lymphoblastic leukemia. J Clin Oncol 2004, 22:1215-1221.
91. Makitie O, Heikkinen R, Toiviainen-Salo S, Henriksson M, Puukko-Viertomies LR, Jahnukainen K Long-term skeletal consequences of childhood acute lymphoblastic leukemia in adult males: a cohort study. Eur J Endocrinol 2013, 168:281-288.
92. Gurney JG, Kaste SC, Liu W, et al. Bone mineral density among long-term survivors of childhood acute lymphoblastic leukemia: results from the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer 2014, 61:1270-1276.
93. Kadan-Lottick N, Marshall JA, Barón AE, Krebs NF, Hambidge KM, Albano E Normal bone mineral density after treatment for childhood acute lymphoblastic leukemia diagnosed between 1991 and 1998. J Pediatr 2001, 138:898-904.
94. Aricò M, Boccalatte MF, Silvestri D, et al. Osteonecrosis: an emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica 2003, 88:747-753.
95. Bürger B, Beier R, Zimmermann M, Beck JD, Reiter A, Schrappe M Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)-experiences from trial ALL-BFM 95. Pediatr Blood Cancer 2005, 44:220-225.
96. Sharma S, Leung WH, Deqing P, et al. Osteonecrosis in children after allogeneic hematopoietic cell transplantation: study of prevalence, risk factors and longitudinal changes using MR imaging. Bone Marrow Transplant 2012, 47:1067-1074.
97. te Winkel ML, Pieters R, Hop WC, et al. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia. J Clin Oncol 2011, 29:4143-4150.
98. Mattano LA, Devidas M, Nachman JB Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial. Lancet Oncol 2012, 13:906-915.
99. Vrooman LM, Stevenson KE, Supko JG, et al. Postinduction dexamethasone and individualized dosing of Escherichia coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study-Dana-Farber Cancer Institute ALL Consortium Protocol 00-01. J Clin Oncol 2013, 31:1202-1210.
100. Mattano LA, Sather HN, Trigg ME, Nachman JB Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. J Clin Oncol 2000, 18:3262-3272.
101. Relling MV, Yang W, Das S, et al. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. J Clin Oncol 2004, 22:3930-3936.
102. Kawedia JD, Kaste SC, Pei D, et al. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. Blood 2011, 117:2340-2347.
103. Paulides M, Dörr HG, Stöhr W, et al. Thyroid function in paediatric and young adult patients after sarcoma therapy: a report from the Late Effects Surveillance System. Clin Endocrinol (Oxf) 2007, 66:727-731.
104. Wallace WH, Thompson L, Anderson RA Long term follow-up of survivors of childhood cancer: summary of updated SIGN guidance. BMJ 2013, 346:f1190.
105. Brown MC, Levitt GA, Frey E, et al. The views of European clinicians on guidelines for long-term follow-up of childhood cancer survivors. Pediatr Blood Cancer 2014, published online Nov 8. 10.1002/pbc.25310.
106. Mulder RL, Kremer LC, Hudson MM, et al. Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol 2013, 14:e621-e629.
107. Armenian S, Hudson M, Mulder R, et al. Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol 2015, 16:e123-e136.
108. Nathan PC, Greenberg ML, Ness KK, et al. Medical care in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol 2008, 26:4401-4409.
109. Ford JS, Chou JF, Sklar CA Attendance at a survivorship clinic: impact on knowledge and psychosocial adjustment. J Cancer Surviv 2013, 7:535-543.
110. Tonorezos ES, Henderson TO Clinical guidelines for the care of childhood cancer survivors. Children 2014, 1:227-240.
111. Kirchhoff AC, Montenegro RE, Warner EL, et al. Childhood cancer survivors' primary care and follow-up experiences. Support Care Cancer 2014, 22:1629-1635.
112. Suh E, Daugherty CK, Wroblewski K, et al. General internists' preferences and knowledge about the care of adult survivors of childhood cancer: a cross-sectional survey. Ann Intern Med 2014, 160:11-17.
113. Nathan PC, Daugherty CK, Wroblewski KE, et al. Family physician preferences and knowledge gaps regarding the care of adolescent and young adult survivors of childhood cancer. J Cancer Surviv 2013, 7:275-282.
114. Bober SL, Recklitis CJ, Campbell EG, et al. Caring for cancer survivors: a survey of primary care physicians. Cancer 2009, 115(suppl):4409-4418.
115. Oeffinger KC, McCabe MS Models for delivering survivorship care. J Clin Oncol 2006, 24:5117-5124.
116. Blaauwbroek R, Tuinier W, Meyboom-de Jong B, Kamps WA, Postma A Shared care by paediatric oncologists and family doctors for long-term follow-up of adult childhood cancer survivors: a pilot study. Lancet Oncol 2008, 9:232-238.
117. Blaauwbroek R, Barf HA, Groenier KH, et al. Family doctor-driven follow-up for adult childhood cancer survivors supported by a web-based survivor care plan. J Cancer Surviv 2012, 6:163-171.
118. Spain PD, Oeffinger KC, Candela J, McCabe M, Ma X, Tonorezos ES Response to a treatment summary and care plan among adult survivors of pediatric and young adult cancer. J Oncol Pract 2012, 8:196-202.
119. Brennan ME, Gormally JF, Butow P, Boyle FM, Spillane AJ Survivorship care plans in cancer: a systematic review of care plan outcomes. Br J Cancer 2014, 111:1899-1908.
120. Work package 13: Quality of survivorship European Network for Cancer Research in Children and Adolescents, (accessed Feb 23, 2015). http://www.encca.eu/project/work-packages.
121. Hudson MM, Leisenring W, Stratton KK, et al. Increasing cardiomyopathy screening in at-risk adult survivors of pediatric malignancies: a randomized controlled trial. J Clin Oncol 2014, 32:3974-3981.
122. Oeffinger KC, Hudson MM, Mertens AC, et al. Increasing rates of breast cancer and cardiac surveillance among high-risk survivors of childhood Hodgkin lymphoma following a mailed, one-page survivorship care plan. Pediatr Blood Cancer 2011, 56:818-824.
123. Mulder RL, Hudson MM, Skinner R, Kremer LC Health problems in survivors of childhood cancer: the need for international collaboration in long-term follow-up care. Future Oncol 2013, 9:1667-1670.
124. Wallace WHB, Blacklay A, Eiser C, et al. Developing strategies for long term follow up of survivors of childhood cancer. BMJ 2001, 323:271-274.
125. Edgar AB, Duffin K, Borthwick S, Marciniak-Stepak P, Wallace WH Can intensity of long-term follow-up for survivors of childhood and teenage cancer be determined by therapy-based risk stratification?. BMJ Open 2013, 3:e002451.